• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非网状内皮组织对小脂质体的摄取。

Uptake of small liposomes by non-reticuloendothelial tissues.

作者信息

Hwang K J, Padki M M, Chow D D, Essien H E, Lai J Y, Beaumier P L

出版信息

Biochim Biophys Acta. 1987 Jul 10;901(1):88-96. doi: 10.1016/0005-2736(87)90259-8.

DOI:10.1016/0005-2736(87)90259-8
PMID:3593727
Abstract

The distribution of liposomes within the intravascular space and the extent to which they escape into extravascular space strongly impact on the application of lipid vesicles as a carrier for pharmacologically active agents. The present study investigates how intact small unilamellar vesicles (SUV) may be taken up by different tissues after intravenous injection into mice, using various types of SUV with different entrapped markers, lipid composition, size, doses of liposomal lipids and stability in the blood. Our focus was specifically on sphingomyelin (or distearoyl phosphatidylcholine)/cholesterol (2:1, mol/mol) SUV, which are known to be stable in the blood circulation. Our results indicated that, in addition to the reticuloendothelial tissues, intact SUV were taken up in several other parts of the body, including intestine, skin, carcass and legs. It appears that the accumulation of SUV in the intestine and the skin increases with time post-injection. Furthermore, from the kinetic data, the process of uptake of SUV by the skin and intestine is compatible with a non-saturable pathway, which follows first-order kinetics. This suggests that the cells involved in the uptake of SUV in the intestine and skin are not phagocytic cells, which are normally saturable.

摘要

脂质体在血管内空间的分布以及它们逸出到血管外空间的程度,对脂质囊泡作为药理活性剂载体的应用有很大影响。本研究调查了完整的小单层囊泡(SUV)在静脉注射到小鼠体内后如何被不同组织摄取,使用了具有不同包封标记物、脂质组成、大小、脂质体脂质剂量和血液稳定性的各种类型的SUV。我们特别关注鞘磷脂(或二硬脂酰磷脂酰胆碱)/胆固醇(2:1,摩尔/摩尔)的SUV,已知它们在血液循环中是稳定的。我们的结果表明,除了网状内皮组织外,完整的SUV还被身体的其他几个部位摄取,包括肠道、皮肤、胴体和腿部。似乎SUV在肠道和皮肤中的积累随着注射后的时间增加。此外,从动力学数据来看,皮肤和肠道摄取SUV的过程与非饱和途径相符,遵循一级动力学。这表明参与肠道和皮肤摄取SUV的细胞不是通常可饱和的吞噬细胞。

相似文献

1
Uptake of small liposomes by non-reticuloendothelial tissues.非网状内皮组织对小脂质体的摄取。
Biochim Biophys Acta. 1987 Jul 10;901(1):88-96. doi: 10.1016/0005-2736(87)90259-8.
2
Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.通过剂量效应将小单层脂质体靶向肝实质细胞。
J Pharmacol Exp Ther. 1989 Feb;248(2):506-13.
3
Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation.脂质体剂量对循环中消除小单层鞘磷脂/胆固醇囊泡的影响。
Res Commun Chem Pathol Pharmacol. 1983 Feb;39(2):277-89.
4
Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition.小单层脂质体在肝内的分布与脂质体脂质组成的关系。
Biochim Biophys Acta. 1986 Dec 16;863(2):224-30. doi: 10.1016/0005-2736(86)90262-2.
5
Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study.单层鞘磷脂/胆固醇脂质体的肝脏摄取与降解:一项动力学研究。
Proc Natl Acad Sci U S A. 1980 Jul;77(7):4030-4. doi: 10.1073/pnas.77.7.4030.
6
Volume of distribution and transcapillary passage of small unilamellar vesicles.小单层囊泡的分布容积与跨毛细血管转运
Life Sci. 1982 Sep 6;31(10):949-55. doi: 10.1016/0024-3205(82)90166-7.
7
Large unilamellar liposomes with low uptake into the reticuloendothelial system.对网状内皮系统摄取率低的大单层脂质体。
FEBS Lett. 1987 Oct 19;223(1):42-6. doi: 10.1016/0014-5793(87)80506-9.
8
Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues.具有延长循环时间的脂质体:影响网状内皮系统及其他组织摄取的因素。
Biochim Biophys Acta. 1989 May 19;981(1):27-35. doi: 10.1016/0005-2736(89)90078-3.
9
Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.脂质体大小和药物释放特性对大鼠体内包封药物药代动力学的影响。
J Pharmacol Exp Ther. 1983 Aug;226(2):539-44.
10
The presence of GM1 in liposomes with entrapped doxorubicin does not prevent RES blockade.在包裹了阿霉素的脂质体中GM1的存在并不能防止网状内皮系统的阻断。
Biochim Biophys Acta. 1993 Jun 12;1168(2):249-52. doi: 10.1016/0005-2760(93)90132-s.

引用本文的文献

1
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective.从美国食品药品监督管理局批准聚乙二醇化脂质体阿霉素(多柔比星脂质体/凯素)至今30年:最新分析与未来展望。
BMJ Oncol. 2025 Jan 9;4(1):e000573. doi: 10.1136/bmjonc-2024-000573. eCollection 2025.
2
Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines.纳米脂质体顺铂和二烯丙基二硫化物对乳腺癌和肺癌细胞系的细胞毒性作用
Biomedicines. 2023 Mar 27;11(4):1021. doi: 10.3390/biomedicines11041021.
3
PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities Passive Extravasation across "Leaky" Endothelium.
聚乙二醇化脂质体蓄积于与皮肤毒性相关的区域 通过“渗漏”的内皮细胞被动渗出
ACS Nano. 2022 Apr 26;16(4):6349-6358. doi: 10.1021/acsnano.2c00423. Epub 2022 Mar 28.
4
Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy.活体显微镜观察系统性注射脂质体在皮肤中的积累动态。
ACS Nano. 2017 Nov 28;11(11):11584-11593. doi: 10.1021/acsnano.7b06524. Epub 2017 Oct 18.
5
Therapeutic applications of extracellular vesicles: clinical promise and open questions.细胞外囊泡的治疗应用:临床前景与待解问题
Annu Rev Pharmacol Toxicol. 2015;55:439-464. doi: 10.1146/annurev-pharmtox-010814-124630. Epub 2014 Oct 3.
6
NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS.用于递送治疗剂和成像剂的纳米级自组装
Technol Innov. 2011 Jan 1;13(1):5-25. doi: 10.3727/194982411X13003853539948.
7
Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.聚乙二醇化脂质体阿霉素的药代动力学:动物和人体研究综述
Clin Pharmacokinet. 2003;42(5):419-36. doi: 10.2165/00003088-200342050-00002.
8
Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome).脂质体柔红霉素(DaunoXome)的I期及药理学研究。
Invest New Drugs. 1994;12(2):103-10. doi: 10.1007/BF00874439.
9
Tumour targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases.抗体偶联脂质体的肿瘤靶向性:在异种移植瘤和自发性肝转移灶中未能实现积聚。
Cancer Immunol Immunother. 1990;31(5):285-91. doi: 10.1007/BF01740936.
10
Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective.脂质体药物递送:从临床药代动力学和治疗学角度看其优势与局限性
Clin Pharmacokinet. 1991 Sep;21(3):155-64. doi: 10.2165/00003088-199121030-00001.